特发性肺纤维化疾病严重程度与生活质量:IPF-PRO登记横断面分析
本研究基于美国多中心IPF-PRO登记2014年6月至2018年7月入组患者的基线数据,纳入829例有完整SGRQ数据的特发性肺纤维化患者,分析客观疾病严重程度指标与生活质量(SGRQ总分)的横断面关联。结果显示,疾病严重程度评分、生理参数及补充氧使用均与更差的生活质量相关。
要点
- 活动时用氧与静息时用氧均与SGRQ总分显著升高相关。
- Dlco%预计值每降低10%,SGRQ总分升高5.0分。
- GAP指数每增1分及CPI每增5分,SGRQ总分分别升高2.9分和3.0分。
核心结论
- 客观疾病严重程度指标(严重程度评分、生理参数及补充氧使用)与IPF患者更差的生活质量相关。
研究设计与样本
- 多中心、美国基于的IPF-PRO登记(NCT01915511)基线数据的横断面分析,纳入829例有完整SGRQ数据的患者。
- 采用多变量校正回归模型检验各严重程度指标与SGRQ总分的横断面关联。
主要发现
- 入组时SGRQ总分中位数(四分位距)为40(26-53),评分越高生活质量越差。
临床怎么用
- 临床可结合GAP指数、CPI、Dlco%预计值及补充氧使用情况评估IPF患者生活质量受损风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited data are available on the association between clinically measured disease severity markers and quality of life (QOL) in idiopathic pulmonary fibrosis (IPF). The study examined the associations between objective disease severity metrics and QOL in a contemporary IPF population. METHODS: This study evaluated baseline data from patients enrolled in the multicenter, US-based Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry between June 2014 and July 2018. Disease severity metrics included FVC % predicted, diffusing capacity for carbon monoxide (Dlco) % predicted, supplemental oxygen use with activity, supplemental oxygen use at rest, and two summary scores (the Gender-Age-Lung Physiology index, based on gender, age, and % predicted values for Dlco and FVC; and the Composite Physiologic Index, based on % predicted values for Dlco, FVC, and FEV1). Multivariable adjusted regression models were used to examine cross-sectional associations between each severity measure and St. George's Respiratory Questionnaire (SGRQ) total score. RESULTS: Among 829 patients with complete SGRQ data, the median (interquartile range) SGRQ score at enrollment was 40 (26-53), with higher scores indicating worse QOL. Modest SGRQ impairments were observed with increasing Gender-Age-Lung Physiology score (2.9 [1.8-4.0] per 1-point increase] and with increasing Composite Physiologic Index scores (3.0 [2.4-3.6] per 5-point increase). Substantial SGRQ impairments were observed for oxygen use with activity (15.6 [12.9-18.2]), oxygen use at rest (16.2 [13.0-19.4]), and decreasing Dlco (5.0 [4.0-6.1] per 10% decrease in % predicted). CONCLUSIONS: Objective measures of disease severity, including severity scores, physiologic parameters, and supplemental oxygen use, are associated with worse QOL in patients with IPF. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT01915511; URL: www.clinicaltrials.gov.
引用
- O'Brien EC, Hellkamp AS, Neely ML, et al. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry. Chest. 2020. PMID: 31954102. doi:10.1016/j.chest.2019.11.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。